Business Information
The group's principal activity is to develop, manufacture and distribute a diversified line of products, systems and services in the health care field. The group manufactures products that deliver fluids and drugs to patients, biopharmaceuticals for the treatment of hemophilia, immune deficiencies and treatment of kidney disease. Operations of the group are classified in three segments: medication delivery, bioscience and renal. The products of the company are used by hospitals, clinical and medical research laboratories, blood dialysis centers, rehabilitation centers, nursing homes, doctors' offices and by patients at home under physician supervision. The group's trademarks are advate, alyx, aralast, arena, baxter, enlightenedhrbc, exeltra, extraneal, intercept, nanoedge, premasol, promaxx, renalsoft and syndeo. The group operates in 29 countries and has sales in over 100 countries. On 20-Oct-2003, the group acquired certain assets of alpha therapeutic corporation.
|
|
Name |
Title
|
Email
|
| Robert Parkinson | Chmn., CEO, Pres. | N/A | | Karenann Terrell | Corporate VP, CIO | N/A | | Norbert Riedel | Corporate VP, Chief Scientific Officer | N/A | | Robert Davis | CFO, Corporate VP | N/A | | Bruce McGillivray | Corporate VP, Pres. - Renal | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 10,378,000 | 1,397,000 | | 2005 | 9,849,000 | 956,000 | | 2004 | 9,509,000 | 388,000
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
